⌘K

Login Start Free

Home/Filings/4/0001213900-24-004999

4//SEC Filing

Szot Matthew K 4

Accession 0001213900-24-004999

CIK 0001937993other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:39 PM ET

Size

5.4 KB

Accession

0001213900-24-004999

Insider Transaction Report

Form 4

Period: 2024-01-18

Cadrenal Therapeutics, Inc.CVKD

Chief Financial Officer

Transactions

Award
Stock Options
2024-01-18+250,000→ 250,000 total
Exercise: $0.94Exp: 2034-01-17→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Cadrenal Therapeutics, Inc.

CIK 0001937993

Entity typeother

Related Parties

1

filerCIK 0001401385

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 7:39 PM ET
Size: 5.4 KB

View on SEC.gov